Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black population.

IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Mallik Greene, Shrey Gohil, Mark Camardo, A Burak Ozbay, Paul Limburg, Jerry Lovelace
{"title":"Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black population.","authors":"Mallik Greene, Shrey Gohil, Mark Camardo, A Burak Ozbay, Paul Limburg, Jerry Lovelace","doi":"10.1080/03007995.2025.2475074","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Colorectal cancer (CRC) poses significant mortality risks, particularly among Black individuals, who experience the highest CRC incidence and mortality rates in the United States. This study examined adherence to multi-target stool DNA (mt-sDNA) testing in this population.</p><p><strong>Methods: </strong>This retrospective cohort analysis used Exact Sciences Laboratories (ESL)-linked claims data from January 2017 to December 2023 on Black patients in the United States aged 45 and older. High-risk individuals, those with payers other than commercial plans, managed care organizations, Medicare Advantage, Medicaid, or Medicare, and individuals with mt-sDNA prescriptions outside the study period were excluded. Adherence was defined as the percentage of patients returning the test kit with valid results within 365 days of shipment. Logistic regression analysis was used to identify factors associated with adherence.</p><p><strong>Results: </strong>Among 434,951 patients included in the study, the overall adherence to mt-sDNA testing was 62.0% (<i>N</i> = 266,981), with a mean time to adherence of 27.6 days (SD = 44.17). Females, older adults (76+ years), and non-metropolitan residents had higher adherence than males, younger adults, and metropolitan patients (all <i>p</i> < 0.001), respectively. Patients with orders from GI specialists had higher adherence than other prescribing clinicians (NP/PA: OR = 0.39, OB/GYN: OR = 0.54, Other: OR = 0.38, PCP: OR = 0.50; all <i>p</i> < 0.001). Digital outreach, especially SMS and email combination, was also associated with higher adherence (OR = 1.25, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>This large, national study found a 62.0% adherence rate to mt-sDNA testing among Black individuals. Higher adherence was associated with being female, older age, non-metropolitan residence, and digital outreach. While the findings highlight the promise of mt-sDNA, further research is needed to explore its full potential in improving CRC screening adherence across different demographic groups.</p>","PeriodicalId":10814,"journal":{"name":"Current Medical Research and Opinion","volume":" ","pages":"1-8"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Research and Opinion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03007995.2025.2475074","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Colorectal cancer (CRC) poses significant mortality risks, particularly among Black individuals, who experience the highest CRC incidence and mortality rates in the United States. This study examined adherence to multi-target stool DNA (mt-sDNA) testing in this population.

Methods: This retrospective cohort analysis used Exact Sciences Laboratories (ESL)-linked claims data from January 2017 to December 2023 on Black patients in the United States aged 45 and older. High-risk individuals, those with payers other than commercial plans, managed care organizations, Medicare Advantage, Medicaid, or Medicare, and individuals with mt-sDNA prescriptions outside the study period were excluded. Adherence was defined as the percentage of patients returning the test kit with valid results within 365 days of shipment. Logistic regression analysis was used to identify factors associated with adherence.

Results: Among 434,951 patients included in the study, the overall adherence to mt-sDNA testing was 62.0% (N = 266,981), with a mean time to adherence of 27.6 days (SD = 44.17). Females, older adults (76+ years), and non-metropolitan residents had higher adherence than males, younger adults, and metropolitan patients (all p < 0.001), respectively. Patients with orders from GI specialists had higher adherence than other prescribing clinicians (NP/PA: OR = 0.39, OB/GYN: OR = 0.54, Other: OR = 0.38, PCP: OR = 0.50; all p < 0.001). Digital outreach, especially SMS and email combination, was also associated with higher adherence (OR = 1.25, p < 0.001).

Conclusions: This large, national study found a 62.0% adherence rate to mt-sDNA testing among Black individuals. Higher adherence was associated with being female, older age, non-metropolitan residence, and digital outreach. While the findings highlight the promise of mt-sDNA, further research is needed to explore its full potential in improving CRC screening adherence across different demographic groups.

在美国黑人新使用者中,坚持使用mt-sDNA检测进行结直肠癌筛查。
目的:结直肠癌(CRC)具有显著的死亡风险,特别是在美国CRC发病率和死亡率最高的黑人人群中。本研究检查了该人群对多靶点粪便DNA (mt-sDNA)检测的依从性。方法:本回顾性队列分析使用了2017年1月至2023年12月美国45岁及以上黑人患者的精确科学实验室(ESL)相关索赔数据。高风险个体、非商业计划、管理式医疗机构、医疗保险优势、医疗补助或医疗保险的支付者以及在研究期间外使用mt-sDNA处方的个体被排除在外。依从性定义为患者在运送后365天内返回具有有效结果的检测试剂盒的百分比。采用Logistic回归分析确定与依从性相关的因素。结果:在纳入研究的434,951例患者中,mt-sDNA检测的总体依从性为62.0% (N = 266,981),平均依从时间为27.6天(SD = 44.17)。女性、老年人(76岁以上)和农村居民的依从性高于男性、年轻人和城市患者(ORs = 1.05;p < 0.001)。从胃肠道专科医生处开处方的患者依从性高于其他开处方的临床医生(NP/PA: OR = 0.39, OB/GYN: OR = 0.54,其他:OR = 0.38, PCP: OR = 0.50;均p < 0.001)。数字外展,特别是短信和电子邮件的结合,也与更高的依从性相关(OR = 1.25, p < 0.001)。结论:这项大型的全国性研究发现,黑人对mt-sDNA检测的依从率为62.0%。较高的依从性与女性、年龄较大、农村居住和数字推广有关。虽然这些发现强调了mt-sDNA的前景,但需要进一步的研究来探索其在改善不同人口群体的CRC筛查依从性方面的全部潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Medical Research and Opinion
Current Medical Research and Opinion 医学-医学:内科
CiteScore
4.40
自引率
4.30%
发文量
247
审稿时长
3-8 weeks
期刊介绍: Current Medical Research and Opinion is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Equivalence, safety and efficacy/effectiveness studies are especially encouraged. Preclinical, Phase I, pharmacoeconomic, outcomes and quality of life studies may also be considered if there is clear clinical relevance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信